Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Get the latest updates from Press releases directly as they happen.
Follow now 558 followers
Last updated about 2 hours ago
about 1 hour ago
Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) is the first and only...
15 days ago
Luke to assume full responsibilities as CEO from 1st January 2026
22 days ago
GSK confirmed today that it will submit a supplemental New Drug Application...
27 days ago
New facilities will bridge R&D and manufacturing across both the US and...
29 days ago
60+ abstracts highlight GSK ambition in respiratory diseases to reduce exacerbations, prevent...
2 months ago
Submission supported by positive phase III data in patients with uncomplicated urogenital...
2 months ago
CureVac will make an upfront settlement of $370 million to GSK
3 months ago
Real-world data shows an association between Recombinant Zoster Vaccine (RZV) and potential...
3 months ago
Includes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for...
3 months ago
Sixth regulatory approval for Blenrep combinations with applications under review in all...
3 months ago
New PDUFA date scheduled for 23 October 2025.